Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pAL119-TK Citations (9)

Originally described in: Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.
Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ, Southgate TD, Klatzmann D, Lassmann H, Castro MG, Loewenstein PR Nat Med. 1999 Nov . 5(11):1256-63. PubMed Journal

Articles Citing pAL119-TK

Articles
Digital switching in a biosensor circuit via programmable timing of gene availability. Lapique N, Benenson Y. Nat Chem Biol. 2014 Dec;10(12):1020-7. doi: 10.1038/nchembio.1680. Epub 2014 Oct 14. PubMed
Development of a genetic sensor that eliminates p53 deficient cells. Mircetic J, Dietrich A, Paszkowski-Rogacz M, Krause M, Buchholz F. Nat Commun. 2017 Nov 13;8(1):1463. doi: 10.1038/s41467-017-01688-w. PubMed
Modeling the pathology, immune responses, and kinetics of HSV-1 replication in the lip scarification model. Egan KP, Allen AG, Wigdahl B, Jennings SR. Virology. 2018 Jan 15;514:124-133. doi: 10.1016/j.virol.2017.11.010. Epub 2017 Nov 22. PubMed
The correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanism. Akbari M, Ebrahimabadi S, Golalipour M, Shahbazi M, Farazmandfar T. J Appl Genet. 2020 Feb;61(1):67-73. doi: 10.1007/s13353-019-00524-9. Epub 2019 Oct 10. PubMed
Quantitative evaluation and comparison of two prodrug-activating suicide gene therapies on oral squamous cell carcinoma. Xu N, Tian H, Fung CP, Lin Y, Zhu G, Shen Y, Yang H. Am J Cancer Res. 2021 Apr 15;11(4):1672-1682. eCollection 2021. PubMed
Live-cell imaging of circadian clock protein dynamics in CRISPR-generated knock-in cells. Gabriel CH, Del Olmo M, Zehtabian A, Jager M, Reischl S, van Dijk H, Ulbricht C, Rakhymzhan A, Korte T, Koller B, Grudziecki A, Maier B, Herrmann A, Niesner R, Zemojtel T, Ewers H, Granada AE, Herzel H, Kramer A. Nat Commun. 2021 Jun 18;12(1):3796. doi: 10.1038/s41467-021-24086-9. PubMed

Associated Plasmids
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. North K, Benbarche S, Liu B, Pangallo J, Chen S, Stahl M, Bewersdorf JP, Stanley RF, Erickson C, Cho H, Pineda JMB, Thomas JD, Polaski JT, Belleville AE, Gabel AM, Udy DB, Humbert O, Kiem HP, Abdel-Wahab O, Bradley RK. Nat Biotechnol. 2022 Jul;40(7):1103-1113. doi: 10.1038/s41587-022-01224-2. Epub 2022 Mar 3. PubMed
Improving the Safety of Mesenchymal Stem Cell-Based Ex Vivo Therapy Using Herpes Simplex Virus Thymidine Kinase. Bashyal N, Lee TY, Chang DY, Jung JH, Kim MG, Acharya R, Kim SS, Oh IH, Suh-Kim H. Mol Cells. 2022 Jul 31;45(7):479-494. doi: 10.14348/molcells.2022.5015. Epub 2022 Mar 21. PubMed
Inhibition of human oral squamous cell carcinoma proliferation and migration by prodrug-activating suicide gene therapies. Xu N, Tian H, Po Fung C, Lin Y, Chen Y, Zhu G, Shen Y, Guo C, Yang H. Exp Ther Med. 2023 Jan 9;25(2):92. doi: 10.3892/etm.2023.11790. eCollection 2023 Feb. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.